Conformationally	conformationally	O	O
restricted	restricted	O	O
analogs	analogs	O	O
of	of	O	O
BD1008	bd1008	O	O
and	and	O	O
an	an	O	O
antisense	antisense	O	O
oligodeoxynucleotide	oligodeoxynucleotide	O	O
targeting	targeting	O	O
sigma1	sigma1	O	O
receptors	receptors	O	O
produce	produce	O	O
anti-cocaine	anti-cocaine	O	O
effects	effects	O	O
in	in	O	O
mice	mice	O	O
.	.	O	O

Cocaine	cocaine	S_chemical	O
's	's	O	O
ability	ability	O	O
to	to	O	O
interact	interact	O	O
with	with	O	O
sigma	sigma	O	O
receptors	receptors	O	O
suggests	suggests	O	O
that	that	O	O
these	these	O	O
proteins	proteins	O	O
mediate	mediate	O	O
some	some	O	O
of	of	O	O
its	its	O	O
behavioral	behavioral	O	O
effects	effects	O	O
.	.	O	O

Therefore	therefore	O	O
,	,	O	O
three	three	O	O
novel	novel	O	O
sigma	sigma	O	O
receptor	receptor	O	O
ligands	ligands	O	O
with	with	O	O
antagonist	antagonist	O	O
activity	activity	O	O
were	were	O	O
evaluated	evaluated	O	O
in	in	O	O
Swiss	swiss	O	O
Webster	webster	O	O
mice	mice	O	O
:	:	O	O
BD1018	bd1018	O	O
(	(	O	O
3S-1-[2-(3,4-dichlorophenyl)ethyl]-1,4-diazabicyclo[4.3.0]nonane	3s-1-[2-(3,4-dichlorophenyl)ethyl]-1,4-diazabicyclo[4.3.0]nonane	S_chemical	O
)	)	O	O
,	,	O	O
BD1063	bd1063	O	O
(	(	O	O
1-[2-(3,4-dichlorophenyl)ethyl]-4-methylpiperazine	1-[2-(3,4-dichlorophenyl)ethyl]-4-methylpiperazine	S_chemical	O
)	)	O	O
,	,	O	O
and	and	O	O
LR132	lr132	O	O
(	(	O	O
1R,2S-(+)-cis-N-[2-(3,4-dichlorophenyl)ethyl]-2-(1-pyrrolidinyl)cyclohexylamine	1r,2s-(+)-cis-n-[2-(3,4-dichlorophenyl)ethyl]-2-(1-pyrrolidinyl)cyclohexylamine	O	O
)	)	O	O
.	.	O	O

Competition	competition	O	O
binding	binding	O	O
assays	assays	O	O
demonstrated	demonstrated	O	O
that	that	O	O
all	all	O	O
three	three	O	O
compounds	compounds	O	O
have	have	O	O
high	high	O	O
affinities	affinities	O	O
for	for	O	O
sigma1	sigma1	O	O
receptors	receptors	O	O
.	.	O	O

The	the	O	O
three	three	O	O
compounds	compounds	O	O
vary	vary	O	O
in	in	O	O
their	their	O	O
affinities	affinities	O	O
for	for	O	O
sigma2	sigma2	O	O
receptors	receptors	O	O
and	and	O	O
exhibit	exhibit	O	O
negligible	negligible	O	O
affinities	affinities	O	O
for	for	O	O
dopamine	dopamine	S_chemical	O
,	,	O	O
opioid	opioid	O	O
,	,	O	O
GABA(A	gaba(a	O	O
)	)	O	O
and	and	O	O
NMDA	nmda	S_chemical	O
receptors	receptors	O	O
.	.	O	O

In	in	O	O
behavioral	behavioral	O	O
studies	studies	O	O
,	,	O	O
pre-treatment	pre-treatment	O	O
of	of	O	O
mice	mice	O	O
with	with	O	O
BD1018	bd1018	O	O
,	,	O	O
BD1063	bd1063	O	O
,	,	O	O
or	or	O	O
LR132	lr132	O	O
significantly	significantly	O	O
attenuated	attenuated	O	O
cocaine-induced	cocaine-induced	O	O
convulsions	convulsions	O	S_disease
and	and	O	O
lethality	lethality	O	O
.	.	O	O

Moreover	moreover	O	O
,	,	O	O
post-treatment	post-treatment	O	O
with	with	O	O
LR132	lr132	O	O
prevented	prevented	O	O
cocaine-induced	cocaine-induced	O	O
lethality	lethality	O	O
in	in	O	O
a	a	O	O
significant	significant	O	O
proportion	proportion	O	O
of	of	O	O
animals	animals	O	O
.	.	O	O

In	in	O	O
contrast	contrast	O	O
to	to	O	O
the	the	O	O
protection	protection	O	O
provided	provided	O	O
by	by	O	O
the	the	O	O
putative	putative	O	O
antagonists	antagonists	O	O
,	,	O	O
the	the	O	O
well-characterized	well-characterized	O	O
sigma	sigma	O	O
receptor	receptor	O	O
agonist	agonist	O	O
di-o-tolylguanidine	di-o-tolylguanidine	O	O
(	(	O	O
DTG	dtg	O	O
)	)	O	O
and	and	O	O
the	the	O	O
novel	novel	O	O
sigma	sigma	O	O
receptor	receptor	O	O
agonist	agonist	O	O
BD1031	bd1031	O	O
(	(	O	O
3R-1-[2-(3,4-dichlorophenyl)ethyl]-1,4-diazabicyclo[4.3.0]nonane	3r-1-[2-(3,4-dichlorophenyl)ethyl]-1,4-diazabicyclo[4.3.0]nonane	S_chemical	O
)	)	O	O
each	each	O	O
worsened	worsened	O	O
the	the	O	O
behavioral	behavioral	O	O
toxicity	toxicity	O	S_disease
of	of	O	O
cocaine	cocaine	S_chemical	O
.	.	O	O

At	at	O	O
doses	doses	O	O
where	where	O	O
alone	alone	O	O
,	,	O	O
they	they	O	O
produced	produced	O	O
no	no	O	O
significant	significant	O	O
effects	effects	O	O
on	on	O	O
locomotion	locomotion	O	O
,	,	O	O
BD1018	bd1018	O	O
,	,	O	O
BD1063	bd1063	O	O
and	and	O	O
LR132	lr132	O	O
significantly	significantly	O	O
attenuated	attenuated	O	O
the	the	O	O
locomotor	locomotor	O	O
stimulatory	stimulatory	O	O
effects	effects	O	O
of	of	O	O
cocaine	cocaine	S_chemical	O
.	.	O	O

To	to	O	O
further	further	O	O
validate	validate	O	O
the	the	O	O
hypothesis	hypothesis	O	O
that	that	O	O
the	the	O	O
anti-cocaine	anti-cocaine	O	O
effects	effects	O	O
of	of	O	O
the	the	O	O
novel	novel	O	O
ligands	ligands	O	O
involved	involved	O	O
antagonism	antagonism	O	O
of	of	O	O
sigma	sigma	O	O
receptors	receptors	O	O
,	,	O	O
an	an	O	O
antisense	antisense	O	O
oligodeoxynucleotide	oligodeoxynucleotide	O	O
against	against	O	O
sigma1	sigma1	O	O
receptors	receptors	O	O
was	was	O	O
also	also	O	O
shown	shown	O	O
to	to	O	O
significantly	significantly	O	O
attenuate	attenuate	O	O
the	the	O	O
convulsive	convulsive	O	S_disease
and	and	O	O
locomotor	locomotor	O	O
stimulatory	stimulatory	O	O
effects	effects	O	O
of	of	O	O
cocaine	cocaine	S_chemical	O
.	.	O	O

Together	together	O	O
,	,	O	O
the	the	O	O
data	data	O	O
suggests	suggests	O	O
that	that	O	O
functional	functional	O	O
antagonism	antagonism	O	O
of	of	O	O
sigma	sigma	O	O
receptors	receptors	O	O
is	is	O	O
capable	capable	O	O
of	of	O	O
attenuating	attenuating	O	O
a	a	O	O
number	number	O	O
of	of	O	O
cocaine-induced	cocaine-induced	O	O
behaviors	behaviors	O	O
.	.	O	O

